Skip to main content
MC

Mediforum Co., Ltd.

Mediforum develops natural compound-based prescription medicines and molecular diagnostics to address neurological diseases, particularly focusing on dementia treatment. The company utilizes advanced research methodologies to enhance preventive medicine through genetic testing, promoting overall health and well-being.

Seoul, South KoreaFounded 2015710+ followers
Updated 20 months ago

Funding

$16.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

ESF
Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Neurological diseases, particularly dementia, pose significant challenges due to limited treatment options and the need for early detection and preventive measures. Traditional approaches often lack effective solutions and comprehensive diagnostic tools for proactive healthcare management.

Solution

Mediforum develops natural compound-based prescription medicines and molecular diagnostics focused on addressing neurological diseases, with a primary emphasis on dementia treatment and prevention. The company utilizes advanced research methodologies to create novel therapeutics and enhance preventive medicine through genetic testing. By leveraging natural compounds and genetic insights, Mediforum aims to provide innovative solutions for managing and mitigating the impact of neurological disorders, promoting overall brain health and well-being. Their approach seeks to move beyond traditional treatments by incorporating early detection and personalized interventions.

Target Audience

The primary target audience includes individuals at risk of or affected by neurological diseases, healthcare providers specializing in neurology and geriatric care, and research institutions focused on neurodegenerative disorders.

Features

  • Development of natural compound-based prescription medicines for neurological diseases
  • Molecular diagnostics for early detection and risk assessment of neurological disorders
  • Genetic testing services to enhance preventive medicine and personalized healthcare
  • Focus on dementia treatment and prevention strategies
  • Utilization of advanced research methodologies for drug discovery and diagnostic development
This profile is AI-generated and may contain inaccuracies.